New York, July 28, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Companion Animal Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Technology, Application, Animal Type, and End User,” the report highlights trends prevailing in the global companion animal diagnostics market and the factors driving market along with those that act as hindrances.
Get Sample PDF Copy of Companion Animal Diagnostics Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00004558/
Companion Animal Diagnostics Market Report Scope & Strategic Insights:
| Report Coverage | Details |
| Market Size Value in | US$ 2.03162 Billion in 2019 |
| Market Size Value by | US$ 2.68486 Billion by 2027 |
| Growth rate | CAGR of 4.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
| No. of Pages | 232 |
| No. Tables | 142 |
| No. of Charts & Figures | 85 |
| Historical data available | Yes |
| Segments covered | Technology ; Application ; Animal Type ; End User ;and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Companion Animal Diagnostics Market: Competitive Landscape and Key Developments
Zoetis Inc., IDEXX laboratories, Inc, Thermo Fisher Scientific Inc, Virbac, Randox Laboratories Ltd, idvet, IDEXX Laboratories, Inc, Heska Corporation, Fujifilm Corporation, and Skyla Corporation are among the leading companies operating in the companion animal diagnostics market.
Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00004558/
- In Feb-2020, Zoetis Inc. acquired of Ethos Diagnostic Science, a veterinary reference lab serving leading specialty animal hospitals. This acquisition has added Ethos Diagnostic’s robust diagnostic portfolio including hematology, clinical chemistry, urinalysis, microbiology, endocrinology, serology, cytology and histology in the company’s portfolio.
- In Jan-2020, Heska Corporation acquired SCIL Animal Care Company to enhance its veterinary diagnostics portfolio and expand the geographic portfolio across North America and Europe.
- In Jan-2020, IDEXX Laboratories, Inc. launched the Vcheck Feline NT-proBNP test kit for cardiac disease in cats with respiratory signsand adult cats prior to anesthesia.
- In Nov-2019, Zoetis acquired ZNLabs that is a veterinary clinical reference laboratory with a network of labs across the U.S. The addition of ZNLabs has strengthened company’s portfolio and expanded its diagnostics footprint in the region.
Growing Prevalence of Chronic Diseases in Pet Animals
Similar to humans, animals too suffer from chronic diseases. Arthritis and other orthopedic conditions, chronic kidney disease, cancer, hepatitis and other liver diseases, skin allergies, diabetes mellitus, inflammatory bowel disease, and thyroid disorders are among the common chronic diseases in pets. Cancer is widespread in animals and affects pet as well as wild animals. Animals have been diagnosed with various types of cancer till date, which have symptoms similar to humans, including weight loss, abnormal swelling, and lethargy. As per the veterinary cancer society, cancer is a leading cause of death in 47% of dogs, especially in dogs of age >10 years, and 32% of cats. Further, FETCH a Cure, a nonprofit organization, has estimated that over 6 million dogs and ~6 million cats would be diagnosed with cancer in 2020. Furthermore, as per the Pet Cancer Facts and Figures, one in four dogs and one in five cats develop cancer in their lifetime. According to the association for pet obesity prevention (APOP), in 2018, ~55.8% of dogs and 59.5% of cats in the US were overweight or obese.
Have a question? Speak to Research Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00004558
The companion animal diagnostics market offerings deal with the epidemiology and pathogenesis of domestic animals and facilitate the prevention of further complications with the health of pets and their owners. The companion animal diagnostics market is expected to witness huge growth due to growing prevalence of chronic diseases in pet animals and increasing adoption of pets for companionship. However, increasing pet care costs and extended pet lifespan are expected to restrain the growth of the market during the forecast period.
Dogs have positive impact on the social and emotional lives of their owners. Dogs also promote an active lifestyle and companionship, which helps relieve stress and anxiety of their owners. As per the 2017–2018 US Pet Ownership & Demographics, around 38.4% of the households in the US were having dogs. Also, the segment is estimated to register the highest CAGR in the market during the forecast period.
Avail Lucrative DISCOUNTS on “Companion Animal Diagnostics Market” Research Study: https://www.theinsightpartners.com/discount/TIPRE00004558/
Companion Animal Diagnostics Market: Segmental Overview
Based on technology, the companion animal diagnostics market is further segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others. The immunodiagnostics segment is further sub-segmented into lateral flow assays, Elisa tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers. Whereas the clinical biochemistry segment is sub-segmented into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. The immunodiagnostics segment held a largest share of the market in 2019owing to the increasing adoption of immunodiagnostic assays such as lateral flow assays, ELISA tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers in the diagnosis of a wide range of disease in pets. However, the clinical biochemistry segment is expected to register a higher CAGR in the market during the forecast period.
Based on application, the companion animal diagnostics market is segmented into bacteriology, clinical pathology, virology, parasitology, and others. The clinical pathology segment accounted for the largest share of the global companion animal diagnostics market in 2019, owing to growing clinical use of biomarkers to detect disease pathogenesis at a molecular level, which helps in clinical decision-making resulting into improved patient outcomes. Also, the segment is estimated to register the highest CAGR in the market during the forecast period.
Based on end user, the companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals and clinics, and research institutes and universities. The diagnostic laboratories segment held the largest share of the market in 2019 owing to increasing diagnostic testing services to detect infectious agents, toxins, and other causes of disease in animal samples. Moreover, adoption of advanced technology and large number of testing services is projected to drive the growth of the segment during the forecast period.
Directly Purchase Premium Copy of Companion Animal Diagnostics Market Growth Report at: https://www.theinsightpartners.com/buy/TIPRE00004558/
Browse Adjoining Reports:
Companion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology Type ( Immunohistochemistry, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], In Situ Hybridization, Others ); Indication ( Oncology, Neurology, Others )
Companion Animal Vaccines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type (Canine Vaccines, Feline Vaccines ); Technology ( Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines ) and Geography
Companion Animal Specialty Drugs Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product Type (Antibiotics Segment, Anti-inflammatory Products Segment, Parasiticides, Heartworm, Behavioral Products, Nutritional Products, Skin Care Products, Vaccines Product); Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores)
Companion Animal Veterinary Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Therapeutics, Diagnostics ); Animal Type ( Dogs, Cats, Other, Companion Animals )
Veterinary Healthcare for Companion Animals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Feed Additives, Pharmaceuticals, Vaccines, Diagnostics, Others); Animal Type (Dogs, Cats, Others); End User (Veterinary Hospitals, Veterinary Clinics, Animal Research Institutes, Others) and Geography
Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type [Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) and Companion Animal Vaccines (Feline Vaccines, Canine Vaccines, and Others)] and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/companion-animal-diagnostics-market
